Morning and welcome to the 2026 Annual Meeting of the Stockholders of NextCure, Inc., being held virtually. I am David Kabakoff, Chair of the Board of Directors of NextCure. There are four items of business on today's agenda. First, the election of two Class I directors. Second, the ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for fiscal year 2026. Third, the approval on an advisory basis of the compensation paid by the company to its named executive officers. Fourth, the approval of an amendment and restatement of our 2019 Omnibus Incentive Plan. I will act as chair of the meeting. If any stockholder would like to comment on any of the proposals, please submit your comment using the Ask a Question feature on the website. We will read comments at the indicated time. In addition, after the business portion of the meeting, we will answer stockholder questions. We will do our best to address as many as possible. However, comments or questions that, among other things, are not related to the proposals under discussion or the business of the company, are about employment matters or personal concerns not shared by the stockholders generally, or use blatantly offensive language, will not be addressed. For more information, please refer to the rules and procedures for the conduct of the annual meeting, which is available on the meeting website. At this time, the meeting is called to order. Now I would like to introduce the other members of the board and company management present today. In addition to me, the other directors present today are Michael Richman, our President and Chief Executive Officer, Anne Borgman, Ellen Feigal, John Houston, Elaine Jones, and Steven Webster. In addition to Mr. Richman, the other executive officers present today are Tim Mayer, our Chief Operating Officer, Steve Cobourn, our Chief Financial Officer, and Kevin Shaw, our Senior VP and General Counsel. We are also joined here today by Tom Sand, representing the company's auditors, Ernst & Young. He will be available to respond to appropriate questions during the question and answer session after the formal portion of the meeting. Beth VanDerb eck, as a representative of Broadridge Financial Solutions, has been appointed to act as Inspector of Election. Ms. VanDerb eck is also with us today. Tim Mayer, our Chief Operating Officer, will act as Secretary of the meeting. I will now turn to him for certain procedural matters. As Dr. Kabakoff mentioned, we will provide time for comments and questions in connection with this meeting. Only validated stockholders may make comments or ask questions in the designated field on the website. Out of consideration for others, please limit yourself to one comment or question. Please note that this meeting is being recorded. However, no one attending via the webcast is permitted to use an audio recording device. The Board of Directors set April 22nd, 2026, as the record date for determining stockholders entitled to vote at this meeting. We have made available a list of stockholders of record as of the close of business on that date, which is available electronically for inspection today by stockholders on the meeting portal. The company has received an affidavit attesting to the fact that a notice of inter net availability of the notice of the meeting was mailed on or about April 24th, 2026, to all stockholders of record as of that date. The affidavit will be made part of the minutes of this meeting. There are present at this meeting in person or by proxy stockholders of record holding in excess of a majority of the company's issued and outstanding shares of the record date. Therefore, a quorum is present for purposes of transacting business and the business of the meeting may proceed. I will now hand the meeting back to Dr. Kabakoff. We will now proceed to transact the business for which this meeting has been called. I will present the matters to be voted on. We will give stockholders an opportunity to comment on the proposals after they have both been presented. The first proposal is the election of Anne Borgman and John Houston as Class I directors, each to serve a three-year term until the 2029 Annual Meeting of Stockholders and until a successor has been duly elected and qualified. Nominees will be elected as directors by a majority of the votes cast. The second proposal is the ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. The affirmative vote of a majority of the votes present in person or represented by proxy is required to ratify this appointment. The third proposal is an advisory vote to approve the compensation of the company's named executive officers. The fourth and final proposal is a vote to approve an amendment and restatement of our 2019 Omnibus Incentive Plan. The affirmative vote of a majority of the votes present in person or represented by proxy is required to approve this amendment and restatement. Our board unanimously recommends a vote for each of our director nominees and a vote for each of the other proposals before stockholders at this meeting. Because no further business is scheduled to come before the stockholders, the polls are now open. Stockholders who have not yet voted or wish to change their vote may do so by clicking on the voting button on the website and following the instructions there. Stockholders who have sent in proxies or voted via telephone or internet and do not want to change their vote do not need to take any further action. Note that only stockholders who are logged into the meeting using their 16-digit control number will be able to vote and submit questions at today's meeting in accordance with the rules and procedures. While stockholders are voting, the meeting is open for discussion relating to the proposals being presented. If any stockholder would like to make a comment or ask a question regarding a proposal, please [audio distortion] to the website now. No comments or questions have been received. We will pause a moment for any final voting. Now that everyone has had the opportunity to vote, the polls for the 2026 annual meeting are officially closed. With that, I once again turn the meeting over to Dr. Kabakoff. Thank you, Tim. We have been informed by the Inspector of Election that the preliminary vote report shows that each of the Class I nominees for election to the board has been duly elected, that the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the year ended December 31, 2026 has been ratified, that the compensation of the company's named executive officers has been approved, and that the amendment and restatement of our 2019 Omnibus Incentive Plan has been approved. We will report the final results in a Form 8-K to be filed within four business days. There being no further business to come before the meeting, the 2026 annual meeting of stockholders of NextCure, Inc. is now adjourned. Now we will open things up for stockholder questions. This session is being webcast live this morning and only stockholders who logged into the web portal with their 16-digit control number will be able to ask questions. We will attempt to ensure that everyone that has a question will have a chance to be heard, and either I or a representative of management will respond to questions. However, in the interest of time, we will limit each individual to one question, and discussion on each question will be limited. Finally, remarks made today may contain forward-looking statements. Actual results could differ materially from those projected. The company undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or other factors. No questions have been received. Seeing no questions at this time, that concludes the question and answer period. I want to thank all of you for attending today's meeting and your continued support of NextCure Inc. Thank you. The meeting has now concluded. Thank you for joining, and have a pleasant day.